Comparison of SARS-CoV-2 Antibody Response by Age Among Recipients of the BNT162b2 vs the mRNA-1273 Vaccine

This cohort study compares antibody responses in a cohort in which both BNT162b2 and mRNA-1273 COVID-19 vaccines were administered.

Detalles Bibliográficos
Autores principales: Richards, Nathan E., Keshavarz, Behnam, Workman, Lisa J., Nelson, Michael R., Platts-Mills, Thomas A. E., Wilson, Jeffrey M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8414189/
https://www.ncbi.nlm.nih.gov/pubmed/34473262
http://dx.doi.org/10.1001/jamanetworkopen.2021.24331

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8414189/
https://www.ncbi.nlm.nih.gov/pubmed/34473262
http://dx.doi.org/10.1001/jamanetworkopen.2021.24331

Ejemplares similares